v3.26.1
LEASES
6 Months Ended
Jun. 30, 2026
Leases  
LEASES

NOTE 5 – LEASES

 

Operating Lease

 

The Company leases approximately 77,000 rentable square feet of office, manufacturing, and assembly space at its principal facility in Carlsbad, California.

 

During the six months ended June 30, 2026, the Company executed an amendment to extend the lease term for this facility by an additional twelve months, establishing a new expiration date of March 31, 2028. The amendment established a revised monthly base rent of approximately $106,000 during the extension period and eliminated the Company’s previously existing options to extend the lease for two additional 60-month periods. Additionally, the amendment stipulates that $0.7 million of the Company’s existing security deposit will be applied toward monthly base rent payments commencing April 1, 2027, reducing the held deposit to $0.3 million over time.

 

As a result of this lease modification, the Company remeasured its lease liability and corresponding right-of-use (ROU) asset based on an updated incremental borrowing rate of 9.75%. This remeasurement resulted in an increase of $1.1 million to both the operating lease ROU asset and operating lease liability.

 

The following table presents supplemental information related to the Company’s operating lease:

  

  

As of

June 30, 2026

  

As of

December 31, 2025

 
Supplemental lease information:          
Weighted average remaining lease term (in years)   1.75    1.25 
Weighted average discount rate   9.75%   8.30%

 

Maturities of operating lease liabilities as of June 30, 2026, are as follows:

 

The following table summarizes the annual contractual maturities of operating lease liabilities (in thousands):

  

  

As of

June 30, 2026

 
2026 (remaining 6 months)  $487 
2027   1,265 
2028   317 
Total minimum lease payments   2,069 
Imputed interest   (170)
Present value of lease liabilities  $1,899 

 

The Company recorded $0.3 million and $0.3 million as operating lease expense for the three months ended June 30, 2026 and 2025, respectively, and $0.5 million and $0.5 million for the six months ended June 30, 2026 and 2025, respectively. This expense is allocated to “General, selling, and administrative” and “Research and development” expenses in the condensed consolidated statements of operations.